Alkermes Starts Phase 3 Program for Narcolepsy Drug Candidate Alixorexton
It will analyze once-daily and split-dose regimens of the oral orexin 2 receptor agonist in people with narcolepsy type 1 and type 2.
Read More
Author: SR Edit Staff
Sleep-Breathing Problems in Severe Spina Bifida Occur Earlier in Life Than Previously Known
A multi-center study reveals that more than half of newborns with myelomeningocele experience sleep-disordered breathing, highlighting a critical need for early screening.
Read More
Study Links High Night-to-Night Variability in OSA to Accelerated Vascular Aging
Real-world data from nearly 30,000 adults suggest single-night assessments may underestimate cardiovascular risks associated with sleep-disordered breathing.
Read More
Nonin Medical Celebrates 40 Years in Pulse Oximetry, Appoints Todd Austin as CEO
The pioneer of fingertip pulse oximetry marks four decades of noninvasive patient monitoring and looks toward connected care solutions for sleep medicine.
Read More
Phase 2 Study Shows Daridorexant Improves Total Sleep Time in Pediatric Insomnia
The dual orexin receptor antagonist demonstrated dose-dependent improvements in objective and subjective sleep outcomes, with a safety profile similar to placebo in children ages 10 to 17.
Read More